Neurocore is Here is Inform About Depression

Depression is more common than individuals may think. In fact, major depression is the leading cause of mental illness in the nation. Neurocore, one of the leading brain performance centers provides assessments for depression. Listed are a few factors to enrich general knowledge about depression.

  1. Outside Risk Factors Do Not Always Have to be Present.

No one factor can solely contribute to depression. However, there are certain risk factors that may increase the likelihood of episodes of depression including trauma and stressful life events such as divorce. There is a biological/genetic link to depression. Thus, an individual is more likely to suffer from depression when there is a family history of the diagnosis. Read more about Neurocore at

  1. Not Everyone Demonstrates Evident Symptoms and Signs.

Sometimes the signs of symptoms of depression are obvious. In this case an individual will likely express a change in appetite, sexual desire, and sleep patterns; individuals may also express feelings of sadness. However, not all individuals express symptoms of depression in an obvious way. In fact, individuals with high functioning depression may reveal very little evidence of depression. These are individuals who are likely to have negative thoughts and feelings that go unexpressed.

  1. There are Multiple Types of Depression.

There is no one type of depression. Common types of depression include: Major Depressive Disorder, Postpartum Depression, and Seasonal Affective Disorder.

  1. Depression has a Negative Influence on the Body.

Depression can cause headaches, stomachaches, and general tension. There is even a difference in brain functioning when an individual is depressed. Follow Neurocore on

  1. Depression is the Leading Cause of Disability(ages 15-44).
  2. Suicide is the Second Leading Cause of Death in Today’s Youth.

And depression is the cause of suicide.

  1. Depression is in Need Funding.

Funding for depression is only 1/100 of that for breast cancer.

  1. Depression Can Be Treated.

A combination of pharmaceutical and therapuetic treatment have proven to be effective in treating depression.

Neurocore provides qEEG brainwave mapping technology to assess symptoms of depression. Furthermore, at Neurocore a customized neurofeedback program is created for each client.


Here’s What Basis, the Sole Product of Elysium Health, Does for Consumers

Elysium Health is an organization that researches, creates, and distributes supplements intended to help people live healthier lives for longer than they would without consuming the products Elysium creates. Elysium Health was founded by two businessmen and a medical researcher.

The basics of Basis, Elysium Health’s flagship supplement

In 2015, the year after Elysium Health was founded, the organization released Basis. Earlier this year, in the early months of 2017, Elysium Health financed the clinical trial of Basis, proving that it does what it states it does – increase the blood serum concentration of NAD+, the initialism of nicotinamide adenine dinucleotide.

Basis is intended to be taken once per day. Two capsules should be taken every morning, as Elysium Health recommends its consumers do, with or without food, meaning it does not typically cause nausea in its consumers. While Basis contains six ingredients, only two of them are active and intended to promote and maintain the cellular health of its consumers: nicotinamide riboside and pterostilbene.

Nicotinamide riboside is intended, once it’s digested, to create stores of nicotinamide adenine dinucleotide in its consumers. Pterostilbene lubricates NAD+ and helps it work as it’s intended.

How can consumers be confident that Basis actually works?

It’s an indisputable fact that many supplements do not have the tried-and-true information backing its manufacturers’ claims. Supplements aren’t regulated by the United States Food and Drug Administration, unlike medications, which are, at least if they’re produced and sold within the United States of America.

Earlier this year, in 2017, Elysium Health funded the clinical trial of the two main ingredients in Basis: nicotinamide riboside and pterostilbene.

The clinical trial involved 120 people and was double-blind, meaning neither doctors nor patients knew whether they were actually taking the real supplement or a placebo, randomized, meaning nobody knew which people actually were taking Basis’ two main ingredients, and standardized. These three characteristics are the three central hallmarks of clinical trials in the United States – and the rest of the world, for that matter.

After taking Basis’ two central components for a total of four straight weeks at least once per day, the serum concentration of nicotinamide adenine dinucleotide – the substance that nicotinamide riboside is designed to yield once consumed – rose an average of 40% in people that took 250 milligrams of nicotinamide riboside and 50 milligrams of pterostilbene. People that took twice this amount – which happens to be the recommended dosage of Basis – were found to have increased 90%. Those that didn’t take anything didn’t see their NAD+ levels rise in any capacity.